Human cord plasma proteomic analysis reveals sexually dimorphic proteins associated with intrauterine growth restriction
© 2023 The Authors. PROTEOMICS published by Wiley‐VCH GmbH..
Intrauterine growth restriction (IUGR) is associated with increased risk of cardiometabolic disease later in life and has been shown to affect female and male offspring differently, but the mechanisms remain unclear. The purpose of this study was to identify proteomic differences and metabolic risk markers in IUGR male and female neonates when compared to appropriate for gestational age (AGA) babies that will provide a better understanding of IUGR pathogenesis and its associated risks. Our results revealed alterations in IUGR cord plasma proteomes with most of the differentially abundant proteins implicated in peroxisome pathways. This effect was evident in females but not in males. Furthermore, we observed that catalase activity, a peroxisomal enzyme, was significantly increased in females (p < 0.05) but unchanged in males. Finally, we identified risk proteins associated with obesity, type-2 diabetes, and glucose intolerance such as EGF containing fibulin extracellular matrix protein 1 (EFEMP1), proprotein convertase subtilisin/kexin type 9 (PCSK9) and transforming growth factor beta receptor 3 (TGFBR3) proteins unique to females while coagulation factor IX (C9) and retinol binding protein 4 (RBP4) are unique in males. In conclusion, IUGR may display sexual dimorphism which may be associated with differences in lifelong risk for cardiometabolic disease between males and females.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Proteomics - 24(2024), 7 vom: 06. Apr., Seite e2300260 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akinyemi, Ayodele Jacob [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/pmic.202300260 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365506842 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365506842 | ||
| 003 | DE-627 | ||
| 005 | 20240408232147.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pmic.202300260 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM365506842 | ||
| 035 | |a (NLM)38059784 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Akinyemi, Ayodele Jacob |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Human cord plasma proteomic analysis reveals sexually dimorphic proteins associated with intrauterine growth restriction |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. PROTEOMICS published by Wiley‐VCH GmbH. | ||
| 520 | |a Intrauterine growth restriction (IUGR) is associated with increased risk of cardiometabolic disease later in life and has been shown to affect female and male offspring differently, but the mechanisms remain unclear. The purpose of this study was to identify proteomic differences and metabolic risk markers in IUGR male and female neonates when compared to appropriate for gestational age (AGA) babies that will provide a better understanding of IUGR pathogenesis and its associated risks. Our results revealed alterations in IUGR cord plasma proteomes with most of the differentially abundant proteins implicated in peroxisome pathways. This effect was evident in females but not in males. Furthermore, we observed that catalase activity, a peroxisomal enzyme, was significantly increased in females (p < 0.05) but unchanged in males. Finally, we identified risk proteins associated with obesity, type-2 diabetes, and glucose intolerance such as EGF containing fibulin extracellular matrix protein 1 (EFEMP1), proprotein convertase subtilisin/kexin type 9 (PCSK9) and transforming growth factor beta receptor 3 (TGFBR3) proteins unique to females while coagulation factor IX (C9) and retinol binding protein 4 (RBP4) are unique in males. In conclusion, IUGR may display sexual dimorphism which may be associated with differences in lifelong risk for cardiometabolic disease between males and females | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cardiometabolic disease | |
| 650 | 4 | |a catalase activity | |
| 650 | 4 | |a compensatory responses | |
| 650 | 4 | |a peroxisome pathways | |
| 650 | 4 | |a sexual dimorphism | |
| 650 | 7 | |a PCSK9 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a Proprotein Convertase 9 |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a RBP4 protein, human |2 NLM | |
| 650 | 7 | |a Retinol-Binding Proteins, Plasma |2 NLM | |
| 650 | 7 | |a EFEMP1 protein, human |2 NLM | |
| 650 | 7 | |a Extracellular Matrix Proteins |2 NLM | |
| 700 | 1 | |a Du, Xiu Quan |e verfasserin |4 aut | |
| 700 | 1 | |a Aguilan, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Sidoli, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, David |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Reznik, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Fuloria, Mamta |e verfasserin |4 aut | |
| 700 | 1 | |a Charron, Maureen J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Proteomics |d 2001 |g 24(2024), 7 vom: 06. Apr., Seite e2300260 |w (DE-627)NLM114023808 |x 1615-9861 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:7 |g day:06 |g month:04 |g pages:e2300260 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/pmic.202300260 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2024 |e 7 |b 06 |c 04 |h e2300260 | ||